Rates Spark: Omicron inversion| MENAFN.COM

Thursday, 20 January 2022 11:38 GMT

Rates Spark: Omicron inversion


The Omicron variant and the winter wave underway in many countries do not subtract from inflation worries – they add to them. Flatter curves are the logical consequence, and some real rates are moving higher too. The US front end continues to trade with a decent rate hike discount. Makes sense to us, especially as hikes are not expected till 2H 2022

In this article
  • The US front end tells a story – hikes are still coming
  • Near-term risks to affect mostly long-end rates
  • While inflation fears keep front-end rates up
  • Today's events and market views

Download article as PDF


Stay up to date with all of ING's latest economic and financial analysis.

Subscribe to THINK The US front end tells a story – hikes are still coming

The likely outcome for market rates in the coming days will likely be a digital reaction to what science has to say on Omicron. Good and bad news has been reacted to so far, with the move lower in yields and acknowledgement that circumstances have in net terms veered towards the worst. But we await a clearer vision on this. We have not, as yet, had confirmation that a follow-through lurch lower in market rates is required, but what we can say is any material break below 1.4% (there is a key technical point at 1.385%) on the US 10yr could quickly take us back to the 1.3% area that we plateaued at through much of the summer. That would be quite a setback for higher end-year yield aspirations.

Despite Omicron, USD OIS are pricing just over 2 hikes next year Refinitiv, ING
Refinitiv, ING

At the same time, the US front end is not taking out any of the rate hike discount. The 2yr remains in the 50-60bp area. Gearing for hikes still makes considerable sense. Remember the hikes are not expected to happen till the second half of 2022. By then, this latest Covid scare should be behind us. We don't have enough to suggest that that should change, and in fact Chair Powell has intimated that a closer scrutiny of inflation risks is warranted. Indeed, the inflation story, while often ignored by the fixed income market in the past number of months, has a persistence about it. If it won't go away, and it looks like it won't (at least not easily) then market rates will have to be ultimately tempted higher.

Near-term risks to affect mostly long-end rates

A winter Covid-19 wave is unwelcome news, and the wave of restrictions associated with them pose a threat to a near-term growth outlook that wasn't brilliant to begin with in Europe. Travel restrictions imposed since the discovery of the Omicron variant add to these concerns, even if they might be reversed within a few weeks, or months. The bias towards pricing negative news was evident once again on Tuesday and we expect markets, through the volatility, to continue trading with a downbeat tone into year-end.

Curve flattening makes sense both on inflation and Covid-19 risk Refinitiv, ING
Refinitiv, ING

In this context, the outperformance of long-dated rates makes sense, although they were probably lent a helping hand so far this week by month-end extension flows. More to the point, we would normally expect curves to bull-flatten on adverse developments. One could question if this applies at the onset of a tightening cycle where front-end rates could in theory price a more dovish path for policy rates on further Covid19-related worries . We think not.

While inflation fears keep front-end rates up

We are inclined to think of the near-term Covid risks to the outlook as factors that are transitory in nature, and that do not necessarily subtract from medium-term inflation fears. The surge in inflation on the other hand can no longer be described as transitory. Fed Chair Powell speaking in favour of faster tapering and yet another upside surprise in Eurozone inflation were clear reminders of that. In other words, it is entirely possible for both Covid-19 and inflation fears to be priced simultaneously by the market. This is most likely to occur via a flattening of the yield curve.

USD and EUR real rates have rebounded on the Omicron scare Refinitiv, ING
Refinitiv, ING

Another take-away is that despite very real near-term worries for the outlook, central banks are taking steps to prepare markets for less monetary support going forward. Powell warning of a faster taper yesterday was the most conspicuous example, but we have documented in previous publications that the ECB is more than aware of upside risks to its inflation forecasts. It took more adverse Covid-19-related news for real rates to notice, tentatively so far, but this is a clear sign that unconditional monetary support can no longer be counted on.

Today's events and market views

November PMIs will spice up an otherwise quiet European morning. Only the Spanish and Italian readings are first releases but the acceleration of the fourth Covid-19 wave in November, and worries related to the new Omicron variant to a lesser extent, increase the chance of downward revisions to preliminary readings.

Germany will auciton 5Y debt.

BoE governor Bailey is scheduled to make a public appearance on the topic of insurance regulation. The event doesn't necessarily lend itself to comments on monetary policy but, with the fate of the December hike on a knife's edge, we will listen in nonetheless.

If this fails to excite markets, ADP employment and ISM manufacturing should, alongside another testimony before Congress by Fed Chair Powell, where he is sure to be asked about inflation. While Powell likely has delivered the message he intended on tapering already (see above), he could take this opportunity to reinforce the message.

Rates Daily Share

Download article as PDF


*Content Disclaimer:
This publication has been prepared by ING solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not constitute investment recommendation, and nor is it investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument. Read more here: https://think.ing.com/about/disclaimer/

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.